What is CareSyntax?
Founded in 2013, CareSyntax operates at the intersection of healthcare technology and risk management. The company leverages a combination of IoT devices and advanced data analytics to provide actionable clinical insights, thereby enabling surgical care providers to mitigate risks more effectively. Its solutions are designed to streamline hospital operations and improve patient outcomes by making critical data accessible and interpretable.
How much funding has CareSyntax raised?
CareSyntax has raised a total of $433.4M across 6 funding rounds:
Private Equity
$11.9M
Unspecified
$20M
Series B
$45.6M
Other Financing Round
$45.6M
Debt
$350K
Series C
$310M
Private Equity (2017): $11.9M with participation from Norgine
Unspecified (2018): $20M led by Surgical
Series B (2019): $45.6M, investors not publicly disclosed
Other Financing Round (2019): $45.6M featuring Plug and Play, IPF Partners, Mitsubishi Corporation, Relyens, Barco Healthcare, and Whiz Partners
Debt (2020): $350K backed by PPP
Series C (2024): $310M with participation from Intel Capital, Lauxera Capital Partners, Arno Capital Partners, PFM Health Sciences, Vesalius Biocapital, Rezayat Group, IPF Partners, Surgical.Ai, Symbiotic Capital, Plug and Play Tech Center, Relyens Group, and Optum Ventures
Key Investors in CareSyntax
Intel Capital
Intel Capital, a division of Intel, invests in innovative startups targeting artificial intelligence, autonomous vehicles, datacenter, Cloud, 5G, and next-generation compute. They are known for curating business development introductions and are headquartered in Santa Clara, California.
Lauxera Capital Partners
Lauxera Capital Partners is an independent, international investment fund focused on growth companies in the Healthtech sector, investing in early profitability stage businesses to enhance efficiency and reduce costs. They have over 800 million euros under management and extensive Healthtech investing experience.
Rezayat Group
Rezayat Group is a diversified conglomerate with operations in 13 countries, involved in trading, construction, investment, industrial services, and more. Founded in 1949, the group has a broad range of activities including IT and telecommunications.
What's next for CareSyntax?
The recent major enterprise-level funding and strategic investment indicate CareSyntax is in a growth phase, likely focusing on expanding its market reach and further developing its technological capabilities. This capital will empower the company to enhance its risk-reduction platforms, potentially explore new healthcare verticals, and solidify its position as a leader in healthcare data analytics and IoT solutions. The company's trajectory suggests a continued emphasis on innovation and strategic partnerships to drive future growth and operational efficiency within the healthcare sector.
See full CareSyntax company page
